Sector consensus Vanda Pharmaceuticals Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 06/09/2024 BST			5-day change	1st Jan Change
5.020 ^USD	-1.18%		-5.10%	+18.96%

07-31	Transcript : Vanda Pharmaceuticals Inc., Q2 2024 Earnings Call, Jul 31, 2024
07-31	Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q2 Revenue $50.5M, vs. Street Est of $47.9M	MT

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
VANDA PHARMACEUTICALS INC.	8.070	+60.76%	3
REGENERON PHARMACEUTICALS, INC.	1,153.73	+1.96%	25
VERTEX PHARMACEUTICALS INCORPORATED	509.82	+8.94%	29
ARGENX SE	510.75	+4.75%	15
BIONTECH SE	99.16	+21.71%	18
BEIGENE, LTD.	272.96	+42.67%	21
GENMAB A/S	2,409.94	+29.57%	17
WUXI APPTEC CO., LTD.	58.36	+50.41%	18
VAXCYTE, INC.	137.86	+23.55%	7
SAREPTA THERAPEUTICS, INC.	193.59	+50.17%	20
INSMED INCORPORATED	87.50	+23.17%	16
NEUROCRINE BIOSCIENCES, INC.	168.72	+40.40%	25
SUMMIT THERAPEUTICS INC.	11.14	+18.87%	3
LEGEND BIOTECH CORPORATION	82.93	+71.74%	19
ZEALAND PHARMA A/S	1,015.14	+22.60%	7
HALOZYME THERAPEUTICS, INC.	59.10	-0.19%	10
EXELIXIS, INC.	27.52	+9.43%	21
PHARMAESSENTIA CORPORATION	856.00	+24.06%	4
ASCENDIS PHARMA A/S	164.78	+53.56%	13
Average	411.95	+29.37%	15
Weighted average by Cap.	648.34	+16.30%	22